13F

Stock

Protalix BioTherapeutics, Inc.

PLX · held by 2 managers

Reported value

$122.2K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$50.4K

Price effect on 2 books still in the name

Largest holder

$103.9K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC82.4K$103.9K−$42.9KCut−$119.9K
Finivi Inc.14.5K$18.3K−$7.56KCut−$7.56K

Positions as of Q1 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.